The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Treatment of Early Childhood Medulloblastoma by Postoperative Chemotherapy Alone
Open accessAbstract
BACKGROUND: The prognosis for young children with medulloblastoma is poor, and survivors are at high risk for cognitive deficits. We conducted a trial of the treatment of this brain tumor by intensive postoperative chemotherapy alone. METHODS: After surgery, children received three cycles of intravenous chemotherapy (cyclophosphamide, vincristine, methotrexate, carboplatin, and etoposide) and intraventricular methotrexate. Treatment was terminated if a complete remission was achieved. Leukoencephalopathy and cognitive deficits were evaluated. RESULTS: Forty-three children were treated according to protocol. In children who had complete resection (17 patients), residual tumor (14), and macroscopic metastases (12), the five-year progression-free and overall survival rates (+/-SE) were 82+/-9 percent and 93+/-6 percent, 50+/-13 percent and 56+/-14 percent, and 33+/-14 percent and 38+/-15 percent, respectively. The rates in 31 patients without macroscopic metastases were 68+/-8 percent and 77+/-8 percent. Desmoplastic histology, metastatic disease, and an age younger than two years were independent prognostic factors for tumor relapse and survival. Treatment strategies at relapse were successful in 8 of 16 patients. There were no major instances of unexpected toxicity. In 19 of 23 children, asymptomatic leukoencephalopathy was detected by magnetic resonance imaging. After treatment, the mean IQ was significantly lower than that of healthy controls within the same age group but higher than that of patients in a previous trial who had received radiotherapy. CONCLUSIONS: Postoperative chemotherapy alone is a promising treatment for medulloblastoma in young children without metastases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Duffner, P. K., Horowitz, M. E., Krischer, J. P., Friedman, H. S., Burger, P. C., Cohen, M. E., Sanford, R. A., Mulhern, R. K., James, H. E., Freeman, C. R., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306173282401 · Cited by 841
Chang, C. H., Housepian, E. M., & Herbert, C. (1969) · Radiology · doi:10.1148/93.6.1351 · Cited by 778
Zeltzer, P. M., Boyett, J. M., Finlay, J. L., Albright, A. L., Rorke, L. B., Milstein, J. M., Allen, J. C., Stevens, K. R., Stanley, P., Li, H., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.3.832 · Cited by 754
Palmer, S. L., Goloubeva, O., Reddick, W. E., Glass, J. O., Gajjar, A., Kun, L., Merchant, T. E., & Mulhern, R. K. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.8.2302 · Cited by 400
Histopathologic grading of medulloblastomas: A Pediatric Oncology Group Study
Eberhart, C. G., Kepner, J. L., Goldthwaite, P. T., Kun, L. E., Duffner, P. K., Friedman, H. S., Strother, D. R., & Burger, P. C. (2002) · Cancer · doi:10.1002/cncr.10189 · Cited by 316
Population-based epidemiologic data on brain tumors in German children
Kaatsch, P., Rickert, C. H., K�hl, J., Sch�z, J., & Michaelis, J. (2001) · Cancer · doi:10.1002/1097-0142(20011215)92:12<3155::aid-cncr10158>3.0.co;2-c · Cited by 309
Biochemical and Clinical Aspects of Methotrexate Neurotoxicity
Vezmar, S., Becker, A., Bode, U., & Jaehde, U. (2003) · Chemotherapy · doi:10.1159/000069773 · Cited by 267
Self-citationFazekas, F. (1989) · European Neurology · doi:10.1159/000116401 · Cited by 214
Medulloblastoma: Present Concepts of Stratification into Risk Groups
Packer, R. J., Rood, B. R., & MacDonald, T. J. (2003) · Pediatric Neurosurgery · doi:10.1159/000071316 · Cited by 161
Patient Demographic and Clinical Features and Circadian Variation in Onset of Ischemic Stroke
Casetta, I., Granieri, E., Fallica, E., la Cecilia, O., Paolino, E., & Manfredini, R. (2002) · Archives of Neurology · doi:10.1001/archneur.59.1.48 · Cited by 149
Ater, J. L., van Eys, J., Woo, S. Y., Moore, B. D., Copeland, D. R., & Bruner, J. (1997) · Journal of Neuro-Oncology · doi:10.1023/a:1005744527443 · Cited by 95
Baram, T. Z., van Eys, J., Dowell, R. E., Cangır, A., Pack, B., & Bruner, J. M. (1987) · Cancer · Cited by 68
Intrathecal Chemotherapy With Antineoplastic Agents in Children
Ruggiero, A., Conter, V., Milani, M., Biagi, E., Lazzareschi, I., Sparano, P., & Riccardi, R. (2001) · Pediatric Drugs · doi:10.2165/00128072-200103040-00001 · Cited by 66
Chemotherapy of central nervous system tumours in infants
Kellie, S. J. (1999) · Child s Nervous System · doi:10.1007/s003810050548 · Cited by 25
Cited by
Kool, M., Korshunov, A., Remke, M., Jones, D. T. W., Schlanstein, M., Northcott, P. A., Cho, Y.-J., Koster, J., Schouten-van Meeteren, A., van Vuurden, D., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0958-8 · Cited by 1,056
Self-citationOutcomes for children and adolescents with cancer: challenges for the twenty-first century
Smith, M. A., Seibel, N. L., Altekruse, S. F., Ries, L. A. G., Melbert, D. L., O'Leary, M., Smith, F. O., & Reaman, G. H. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.0421 · Cited by 1,026
“An apparent improvement in outcome for younger children with medulloblastoma for the most recent reporting period may reflect increasing use of intensive chemotherapy, with or without autologous stem cell rescue, to delay or eliminate use of radiation therapy.(29,30) Bone sarcomas (osteosarcoma and Ewing sarcoma).”
BackgroundTargeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma
Huse, J. T., & Holland, E. C. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2818 · Cited by 763
Kool, M., Koster, J., Bunt, J., Hasselt, N. E., Lakeman, A., van Sluis, P., Troost, D., Meeteren, N. S.-V., Caron, H. N., Cloos, J., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003088 · Cited by 722
Self-citationNorthcott, P. A., Robinson, G. W., Kratz, C. P., Mabbott, D. J., Pomeroy, S. L., Clifford, S. C., Rutkowski, S., Ellison, D. W., Malkin, D., Taylor, M. D., et al. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0063-6 · Cited by 649
Self-citation
Metadata
- Authors
- Rutkowski, S., Bode, U., Deinlein, F., Ottensmeier, H., Warmuth-Metz, M., Soerensen, N., Graf, N., Emser, A., Pietsch, T., Wolff, J. E. A., Kortmann, R. D., & Kuehl, J.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2005-03-10
- Volume
- 352
- Issue
- 10
- Pages
- 978-986
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2071064669
- Cited by
- 751
- References
- 14
- FWCI
- 20.17
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.